New Treatment Option May Be on the Horizon for Polymyalgia Rheumatica
Hospital for Special SurgeryA drug approved to treat rheumatoid arthritis, tocilizumab, yielded favorable results as a potential new therapy for patients with polymyalgia rheumatica in an open-label, phase II study at Hospital for Special Surgery.